Upcoming Conferences to Attend

  • 37th WORLD CONGRESS World Congress Collegium Internationale Neuro-Psychopharmacologicum, Glasgow, UK, 2026.6.26-29
  • 26TH WORLD CONGRESS OF PSYCHIATRY, Stockholm, Sweden, 2026.9.23-26
  • The 11th World Congress of Asian Psychiatry, Sapporo, Japan, 2026.10.6-8

Publication (English)

  1. Matsuo K, Watanabe M, Inamine S, Matsushima T, Kyuragi S, Maeda Y, Katsuki R, Ohgidani M, Yamasaki R, Isobe N, Nakao T, Kato TA.: The flow cytometric analysis of depression focusing on modern-type depression and hikikomori: Exploring the link between subtypes of depression and immunological imbalances. Dialogues in Clinical Neuroscience. 2025;27(1):13-25. doi:10.1080/19585969.2025.2452842
  2. Reina, S., Kubo, T., Orsolini, L., Matsushima, T., Kyuragi, S., Matsuo, K., Nakao, T., Volpe, U., & Kato, T. A. (2025). Hikikomori Diagnostic Evaluation-Screening Form (HiDE-S): A validation study. Psychiatry and clinical neurosciences, 79(8), 496–497. https://doi.org/10.1111/pcn.13837
  3. Kyuragi S, Inamine S, Ohgidani M, Kato TA. Human monocyte-derived microglia-like (iMG) cells: A tool to explore microglial dynamics. Clin Exp Neuroimmunol. 2024; 15(4): 222–227.
  4. Kyuragi, S., Inamine, S., Ohgidani, M., Kato, T. A. Engineering of Human Blood-Induced Microglia-like Cells for Reverse-Translational Brain Research. J. Vis. Exp. (211), e66819, doi:10.3791/66819 (2024).
  5. Masuda, R., Katsuki, R., Matsushima, T., Kyuragi, S., Nakao, T., & Kato, T. A. (2024). Does childhood maltreatment affect hikikomori via traits of modern-type depression?. Journal of affective disorders, 360, 50–54. doi: 10.1016/j.jad.2024.05.094.
  6. Kyuragi, S., Matsushima, T., Matsuo, K., Nakao, T., & Kato, T. A. (2023). High-sensitivity C-reactive protein and bilirubin as possible biomarkers for hikikomori in depression: A case-control study. Psychiatry and clinical neurosciences, 77(8), 458–460. doi: 10.1111/pcn.13564.
  7. Ohgidani, M., Kushima, I., Inamine, S., Kyuragi, S., Sagata, N., Nakao, T., Kanba, S., Ozaki, N., & Kato, T. A. (2023). A case of bipolar disorder with AIF1 (coding gene of Iba-1) deletion: A pilot in vitro analysis using blood-derived microglia-like cells. Psychiatry and clinical neurosciences, 77(2), 128–130. doi: 10.1111/pcn.13505.
  8. Sato-Kasai, M., Kato, T. A., Ohgidani, M., Mizoguchi, Y., Sagata, N., Inamine, S., Horikawa, H., Hayakawa, K., Shimokawa, N., Kyuragi, S., Seki, Y., Monji, A., & Kanba, S. (2016). Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7. Schizophrenia research, 178(1-3), 35–43. doi: 10.1016/j.schres.2016.08.022.

Publication (Japanese)

  1. 久良木 聡太, 加藤 隆弘：ミクログリアと精神疾患・心身症. 精神医学, 68巻2号: 150-155, 2026.2
  2. 久良木 聡太, 加藤 隆弘：統合失調症におけるミクログリアを介した神経免疫仮説. ファルマシア, 61(9):832-836, 2025.9
  3. 久良木 聡太, 加藤 隆弘：うつ病における炎症と免疫, 炎症と免疫, 32(4):  294-297, 2024
  4. 久良木 聡太, 稲嶺 翔吾, 扇谷 昌宏, 加藤 隆弘：ヒト血液単球由来ミクログリア様細胞を用いた橋渡しリバーストランスレーショナル研究, 臨床精神医学, 53(4):435-442, 2024.

Presentations at International Academic Conferences

  1. Sota Kyuragi: Patterns of Antidepressant Use in Asia: Bayesian Modelling Framework Based on Real-World Prescription Data from the REAP-AD3 Survey.　 The 24th Korea–Japan Young Psychiatrists’ Conference, 2026.2.7, Seoul, Korea. (ポスター、Nishizono-Min award受賞)
  2. Sota Kyuragi: Patterns of Antidepressant Prescription in Asia: Findings from the REAP-AD3 Survey. EAACP, 2025.11.21, Taipei, Taiwan（シンポジウム口頭発表）
  3. Sota Kyuragi: Patterns of Antidepressant Use in Asia: Findings from the REAP-AD3 Survey.　PRCP & WACP Joint Congress 2025, 2025.9.28, Tokyo, Japan（シンポジウム口頭発表）
  4. Sota Kyuragi: Development of biomarkers of hikikomori focusing on inflammation and microglia.　PRCP & WACP Joint Congress 2025, 2025.9.27, Tokyo, Japan（シンポジウム口頭発表）
  5. Kyuragi S, et al. “Current Trend of Antidepressant Prescription Patterns in Asia: Findings from the REAP-AD3 Study”, THE 10TH WORLD CONGRESS ASIAN PSYCHIATRY, Bali, Indonesia, December 5, 2024. （シンポジウム口頭発表、Early-Career Psychiatrist Session Award受賞）
  6. Kyuragi S, et al. “High-Sensitivity C-Reactive Protein and Bilirubin as Possible Biomarkers for Hikikomori in Depression”, THE 10TH WORLD CONGRESS ASIAN PSYCHIATRY, Bali, Indonesia, December 6, 2024. （ポスター）
  7. Kyuragi S, et al. “Immunological perspectives in bipolar disorder: Transcriptomic analysis of induced microglia-like (iMG) cells”, 24TH WORLD CONGRESS OF PSYCHIATRY, Mexico City, Mexico, November 14, 2024. （ポスター）
  8. Kyuragi S, et al. “Antidepressant Prescription Trends in East Asian Country: An Overview of REAP-AD3 Survey.”, 2024 International Psychiatric Conference of Asia, Asia-Pacific, SAARC and Middle East Psychiatric Federations, Abu Dhabi, U.A.E., June 2, 2024. （シンポジウム口頭発表）
  9. Kyuragi S, et al. “Possible immunological pathophysiology in bipolar disorder: Reverse-translational research using induced microglia-like (iMG) cells.” 35th WORLD CONGRESS World Congress Collegium Internationale Neuro-Psychopharmacologicum,Tokyo, Japan, May 26, 2024. (ポスター、Student Encouragement Award受賞)
  10. Kyuragi S, et al. “Possible immunological pathophysiology in bipolar disorder: Utility of induced microglia-like (iMG) cells for reverse-translational research.” SOCIETY OF BIOLOGICAL PSYCHIATRY 2024 Annual Meeting, Texas, U.S.A., May 11, 2024. (ポスター)
  11. Kyuragi S, et al. “Reverse-translational Research using cellular models.” 22nd Korea-Japan Young Psychiatrist’s Conference, Fukuoka, Japan, October 5, 2022. (口頭発表)

Presentations at Japanese Academic Conferences

  1. 久良木聡太、他8名“ヒトミクログリア・神経モデル細胞を用いた双極性障害の病態解明研究“ BPCNPNP2025、京都府、2025年11月13日　(ポスター、若手優秀発表賞)
  2. 久良木聡太、他5名“双極性障害患者由来induced microglia-like cells (iMG細胞)を用いたRNA sequence解析” NEURO 2024、福岡、2024年7月26日　(口頭発表)
  3. 久良木聡太、他5名“双極性障害患者由来induced microglia-like cells (iMG細胞)のRNA sequence解析” 第8回日本骨免疫学会ウインタースクール、長野、2024年1月31日　(ポスター)
  4. 久良木聡太、他5名“双極性障害患者由来induced microglia-like cells (iMG細胞)のRNA sequence解析” 第45回日本生物学的精神医学会年会、東京、2023年11月6日　(ポスター)
  5. 久良木聡太、他5名“SARS-Cov-2 スパイク蛋白に対するinduced microglia-like cells (iMG細胞)の反応性の解析”第66回日本神経化学会大会、兵庫、2023年7月7日　(ポスター)
  6. 久良木聡太、他5名“SARS-Cov-2 スパイク蛋白に対するinduced microglia-like cells (iMG細胞)の反応性の解析” 第44回日本生物学的精神医学会年会、東京、2022年11月5日　(ポスター)

Books, etc.

  1. Participation in the Japanese translation of “Diagnostic and statistical manual of mental disorders : DSM-5-TR. American Psychiatric Association, 2022.”
    Takahashi S, Ono H: DSM-5-TR 精神疾患の診断・統計マニュアル. IGAKU-SHOIN Ltd., 2023
  2. Kato TA, Matsushima T, Matsuo K, Kyuragi S, Minohara T, Oishi M, Kayo M: 心のケアにたずさわる人が知っておきたい　精神系のくすり(Psychotropic drugs that mental health care providers should know about). MEDICUS SHUPPAN, Publishers Co., Ltd., 2022
  3. Kato TA, et al. :心のケアにたずさわる人が知っておきたい精神疾患とストレス関連疾患(Mental disorders and stress-related disorders that mental health professionals should know about). MEDICUS SHUPPAN, Publishers Co., Ltd., 2024